Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 25.48%39.95M | 95.24%42.5M | 81.42%35.84M | 35.14%109.03M | 126.59%35.68M | 102.99%31.84M | 4.13%21.77M | -30.32%19.75M | -43.72%80.68M | -56.16%15.75M |
| Cost of revenue | 19.90%28.45M | 65.22%30.23M | 48.79%26.49M | 28.00%87.98M | 94.82%28.15M | 61.00%23.73M | 3.87%18.29M | -18.82%17.8M | -35.11%68.73M | -42.37%14.45M |
| Gross profit | 41.81%11.49M | 253.46%12.27M | 378.85%9.35M | 76.21%21.05M | 481.00%7.52M | 758.58%8.11M | 5.53%3.47M | -69.58%1.95M | -68.08%11.95M | -88.06%1.3M |
| Operating expense | -16.33%6.35M | 108.63%7.67M | 63.89%5.51M | 33.40%20.54M | -3.88%4.12M | 73.70%7.59M | 74.92%3.68M | -13.28%3.36M | -16.46%15.4M | -37.90%4.28M |
| Selling and administrative expenses | -26.94%6.03M | 29.79%5.72M | 44.48%5.62M | 24.37%21.41M | 81.17%5.12M | 54.48%8.25M | 27.99%4.41M | -30.65%3.89M | -19.76%17.22M | -50.32%2.83M |
| -Selling and marketing expense | 40.02%2.62M | 59.50%2.4M | 83.91%2.39M | 46.40%6.78M | 56.64%2.11M | 48.33%1.87M | 65.13%1.51M | 16.50%1.3M | 2.43%4.63M | 6.14%1.35M |
| -General and administrative expense | -46.55%3.41M | 14.37%3.32M | 24.71%3.23M | 16.25%14.63M | 103.52%3.01M | 56.37%6.38M | 14.61%2.9M | -42.35%2.59M | -25.68%12.58M | -66.53%1.48M |
| Other operating expenses | --323K | --1.95M | ---- | --251.47K | ---- | ---- | ---- | ---- | ---- | --1.46M |
| Total other operating income | ---- | ---- | -79.32%109K | -38.23%1.12M | --1M | -32.03%660K | -45.42%733K | -69.56%527K | -39.82%1.82M | ---- |
| Operating profit | 896.90%5.14M | 2,368.47%4.61M | 372.68%3.84M | 114.91%514.34K | 214.02%3.41M | 115.07%516K | -117.07%-203K | -155.41%-1.41M | -118.15%-3.45M | -175.75%-2.99M |
| Net non-operating interest income (expenses) | -36.52%-471K | -36.55%-396K | -11.70%-315K | 4,917.28%453.01K | -75.00%-427K | -144.68%-345K | -66.67%-290K | -41.71%-282K | 102.52%9.03K | -225.70%-244K |
| Non-operating interest income | ---- | ---- | ---- | 133.97%1.8M | ---- | ---- | ---- | ---- | 91.44%768.08K | ---- |
| Non-operating interest expense | 36.52%471K | 36.55%396K | 11.70%315K | 77.07%1.34M | 75.00%427K | 144.68%345K | 66.67%290K | 41.71%282K | -0.01%759.05K | 17.82%244K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 2,632.75%4.67M | 953.75%4.21M | 308.57%3.53M | 128.12%967.35K | 192.20%2.98M | 104.80%171K | -148.57%-493K | -172.14%-1.69M | -118.45%-3.44M | -178.10%-3.23M |
| Income tax | 1,522.86%1.14M | 1,120.20%1.01M | 329.89%846K | -345.28%-3.43M | -1,032.00%-3.03M | 103.96%70K | -302.04%-99K | -158.88%-368K | -119.59%-769.43K | 390.56%325K |
| Net income | 3,401.98%3.54M | 911.93%3.2M | 302.65%2.68M | 264.51%4.39M | 268.93%6.01M | 105.62%101K | -140.79%-394K | -176.96%-1.32M | -118.15%-2.67M | -183.69%-3.56M |
| Net income continuous operations | 3,401.98%3.54M | 911.93%3.2M | 302.65%2.68M | 264.51%4.39M | 268.93%6.01M | 105.62%101K | -140.79%-394K | -176.96%-1.32M | -118.15%-2.67M | -183.69%-3.56M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 3,401.98%3.54M | 911.93%3.2M | 302.65%2.68M | 264.51%4.39M | 268.93%6.01M | 105.62%101K | -140.79%-394K | -176.96%-1.32M | -118.15%-2.67M | -183.69%-3.56M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 3,401.98%3.54M | 911.93%3.2M | 302.65%2.68M | 264.51%4.39M | 268.93%6.01M | 105.62%101K | -140.79%-394K | -176.96%-1.32M | -118.15%-2.67M | -183.69%-3.56M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 3,500.00%0.0072 | 912.50%0.0065 | 300.00%0.0054 | 250.85%0.0089 | 254.43%0.0122 | 104.88%0.0002 | -134.78%-0.0008 | -167.50%-0.0027 | -117.20%-0.0059 | -179.80%-0.0079 |
| Diluted earnings per share | 3,500.00%0.0072 | 912.50%0.0065 | 300.00%0.0054 | 250.85%0.0089 | 253.16%0.0121 | 104.88%0.0002 | -134.78%-0.0008 | -167.50%-0.0027 | -117.20%-0.0059 | -179.80%-0.0079 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.